MétaCan
Menu
← Back to cohort
Record W4411846559 · doi:10.3899/jrheum.2025-0314.21

Certolizumab Inhibits Radiographic Progression Even in Rheumatoid Arthritis Patients with High Rheumatoid Factor Levels: A Pooled, Post Hoc Analysis of Two Phase 3 Trials

2025· article· en· W4411846559 on OpenAlexaffvenue
Shahin Jamal, Josef S Smolen, Gerd R Burmester, Yoshiya Tanaka, Tsutomu Takeuchi, Jeffrey R. Curtis, Ted R. Mikuls, Clementina López‐Medina, Peter C. Taylor, Nicola Tilt, Bernard Lauwerys, Baran Ufuktepe

Bibliographic record

VenueThe Journal of Rheumatology · 2025
Typearticle
Languageen
FieldMedicine
TopicRheumatoid Arthritis Research and Therapies
Canadian institutionsArthritis Research Centre of CanadaResearch Canada
Fundersnot available
KeywordsMedicineRheumatoid arthritisPost-hoc analysisPost hocInternal medicineRheumatoid factor

Abstract

fetched live from OpenAlex

Objectives To assess radiographic progression in certolizumab pegol (CZP)+methotrexate (MTX) vs placebo (PBO)+MTX-treated patients (pts) with rheumatoid arthritis (RA), stratified by rheumatoid factor (RF) level, in the C-EARLY ( NCT01519791 ) and C-OPERA ( NCT01451203 ) phase 3 randomized trials. Methods A pooled analysis of pts with early (≤1 year active disease) moderate-to-severe RA with poor prognostic factors in the C-EARLY and C-OPERA trials is presented (full analysis set). At Week (Wk)24, PBO-treated non-responders could switch to CZP for the remaining 28 wks (early escapers). Pts were stratified by baseline (BL) RF level (low: <200 IU/mL; high: ≥200 IU/mL), per published strata.[1,2] Change from BL in modified total Sharp score (mTSS) and proportions of pts experiencing minimum clinically important difference (worsening) of mTSS (>5) at Wk24 and Wk52 are reported. Results 813 CZP-treated (low RF: N=571; high RF: N=242) and 367 PBO-treated (low RF: N=242; high RF: N=125) pts with BL RF measurements were included; 56 PBO-treated pts were early escapers. BL characteristics were similar between CZP- and PBO-treated pts within each RF stratification. However, pts with high RF had more severe disease at BL than those with low RF, with higher mean C-reactive protein, anti-citrullinated protein antibodies, mTSS, and erosion scores. By Wk52, mean mTSS increased from BL in PBO-treated pts with both high RF (change from BL [CfB]: 2.36±6.20) and low RF (CfB: 1.37±3.43) but was comparable in CZP-treated pts (high RF, CfB: 0.28±2.63; low RF, CfB: 0.14±3.11). The proportion of pts with meaningfully worsening radiographic progression was higher in PBO-treated pts with high RF compared to low RF at both Wk24 (6.48% vs 2.84%) and Wk52 (17.59% vs 10.43%) (Figure). By contrast, a smaller proportion of CZP-treated pts experienced meaningful worsening and this was similar between pts with high and low RF (Wk24: 0.00% vs 1.05%; Wk52: 5.29% vs 3.14%, respectively). Figure. Individual pt CfB in mTSS at Wk24 and Wk52, stratified by baseline RF level (low [<200 IU/mL] vs high [≥200 IU/mL]) Conclusion Pts with high BL RF levels had more severe RA and BL radiographic damage than those with low RF. Worsening radiographic damage was observed in PBO-treated pts, with slightly greater progression in high RF pts than low RF. In contrast, irrespective of BL RF levels, CZP-treated pts demonstrated consistently lower radiographic progression, suggesting RF does not adversely influence radiographic response to CZP. Previously submitted to: ACR 2024. [1.] Vastesaeger N. Rheumatology (Oxford) 2009;48:1114-21; [2.] Smolen J. Arthritis Rheumatol 2023;75(suppl 9).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.022
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.022
Threshold uncertainty score0.115

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0220.016
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0090.016
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.326
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Rheumatology→Same topicRheumatoid Arthritis Research and Therapies→French-language works237,207→